OBJECTIVE: To determine the loss to follow-up (LTFU) rates at different healthcare levels after antiretroviral therapy (ART) services decentralisation among ART patients who initiated ART between 2004 and 2017 using the competing risk model in addition to the Kaplan-Meier and Cox regressions analysis. DESIGN: A retrospective cohort study. SETTING: The study was done in Zimbabwe using a nationwide routinely collected HIV patient-level data from various health levels of care facilities compiled through the electronic patient management system (ePMS). PARTICIPANTS: We analysed 390 771 participants aged 15 years and above from 538 health facilities. OUTCOMES: The primary endpoint was LTFU defined as a failure of a patient to report for drug ref...
BACKGROUND: Loss to follow-up (LTF) challenges the reporting of antiretroviral treatment (ART) progr...
Background: Antiretroviral therapy (ART) improves morbidity and mortality in patients with HIV, howe...
OBJECTIVE: To determine the rate and predictors of early loss to follow-up (LTFU) for recently diagn...
Antiretroviral therapy (ART) improves morbidity and mortality in patients with HIV, however high rat...
Background: Loss to follow-up (LTFU) is common in antiretroviral therapy (ART) programmes. Mortality...
BACKGROUND: Loss to follow-up (LTFU) is common in antiretroviral therapy (ART) programmes. Mortality...
BACKGROUND: Loss to follow-up (LTFU) is common in antiretroviral therapy (ART) programmes. Mortality...
Background Loss to follow-up (LTFU) is common in antiretroviral therapy (ART) programmes. Mortali...
Includes bibliographical referencesOver the past decade, antiretroviral therapy (ART) programmes hav...
Lifelong antiretroviral therapy (ART) improves health outcomes for HIV-positive individuals, but is ...
Antiretroviral therapy (ART) improves morbidity and mortality in patients with HIV, however high rat...
Loss to follow-up (LTFU) is common in antiretroviral therapy (ART) programmes. Mortality is a compet...
BACKGROUND: Evaluation of antiretroviral treatment (ART) programmes in sub-Saharan Africa is difficu...
Evaluation of antiretroviral treatment (ART) programmes in sub-Saharan Africa is difficult because m...
Although several studies have explored factors associated with loss to follow-up (LTFU) from HIV car...
BACKGROUND: Loss to follow-up (LTF) challenges the reporting of antiretroviral treatment (ART) progr...
Background: Antiretroviral therapy (ART) improves morbidity and mortality in patients with HIV, howe...
OBJECTIVE: To determine the rate and predictors of early loss to follow-up (LTFU) for recently diagn...
Antiretroviral therapy (ART) improves morbidity and mortality in patients with HIV, however high rat...
Background: Loss to follow-up (LTFU) is common in antiretroviral therapy (ART) programmes. Mortality...
BACKGROUND: Loss to follow-up (LTFU) is common in antiretroviral therapy (ART) programmes. Mortality...
BACKGROUND: Loss to follow-up (LTFU) is common in antiretroviral therapy (ART) programmes. Mortality...
Background Loss to follow-up (LTFU) is common in antiretroviral therapy (ART) programmes. Mortali...
Includes bibliographical referencesOver the past decade, antiretroviral therapy (ART) programmes hav...
Lifelong antiretroviral therapy (ART) improves health outcomes for HIV-positive individuals, but is ...
Antiretroviral therapy (ART) improves morbidity and mortality in patients with HIV, however high rat...
Loss to follow-up (LTFU) is common in antiretroviral therapy (ART) programmes. Mortality is a compet...
BACKGROUND: Evaluation of antiretroviral treatment (ART) programmes in sub-Saharan Africa is difficu...
Evaluation of antiretroviral treatment (ART) programmes in sub-Saharan Africa is difficult because m...
Although several studies have explored factors associated with loss to follow-up (LTFU) from HIV car...
BACKGROUND: Loss to follow-up (LTF) challenges the reporting of antiretroviral treatment (ART) progr...
Background: Antiretroviral therapy (ART) improves morbidity and mortality in patients with HIV, howe...
OBJECTIVE: To determine the rate and predictors of early loss to follow-up (LTFU) for recently diagn...